Thera Tablets (Harvard Drug) – labeling issue (2014)
Class III: A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences
Class III recall indicates unlikely adverse health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Thera Tablets with Beta Carotene Dietary Supplement
Brand
The Harvard Drug Group, LLC
Lot Codes / Batch Numbers
Lot Number: M-00953 Expiration Date: 06-2015, UPC Code: 3 09040 53961 8
Products Sold
Lot Number: M-00953 Expiration Date: 06-2015, UPC Code: 3 09040 53961 8
The Harvard Drug Group, LLC is recalling Thera Tablets with Beta Carotene Dietary Supplement due to The firm received a complaint that the blister packets were missing labeling information on 12/16/2014, the firm investigated the labeling complaint a. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
The firm received a complaint that the blister packets were missing labeling information on 12/16/2014, the firm investigated the labeling complaint and found that six 2 x 5 blister cards inside a carton was missing some or all of the product information on the back of the blister card.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
AL, AZ, CA, CO, CT, FL, GA, IL, KY, MA, MI, MS, MO, NE, NJ, NY, NC, OH, OR, PA, TN, TX, UT, VA, WA, WV, WI
Page updated: Jan 6, 2026